Premkumar, Daniel R. D., Rangnath R. Mishra, Jeffery L. Overholt, Michael S. Simonson, Neil S. Cherniack, and Nanduri R. Prabhakar. L-type Ca 2ϩ channel activation regulates induction of c-fos transcription by hypoxia. J Appl Physiol 88: [1898][1899][1900][1901][1902][1903][1904][1905][1906] 2000.-In the present study we examined the intracellular pathways that link hypoxia to activation of c-fos gene expression. Experiments were performed on rat pheocromocytoma-12 (PC-12) cells. c-fos mRNA and promoter activities were analyzed by RT-PCR and reporter gene assays, respectively. BAPTA, a Ca 2ϩ chelator, inhibited c-fos mRNAand promoter activation by hypoxia. Nitrendipine, an L-type Ca 2ϩ -channel blocker, abolished, whereas BAY K 8644, an L-type channel agonist, enhanced c-fos activation by hypoxia. Ca 2ϩ currents were augmented reversibly by hypoxia, suggesting that Ca 2ϩ influx mediated by L-type Ca 2ϩ channels is essential for c-fos activation by hypoxia. We next determined downstream pathways activated by intracellular Ca 2ϩ concentration. Immunoblot analysis revealed Ca 2ϩ /calmodulin-dependent kinase II (CaMKII) protein in PC-12 cells and revealed that hypoxia increased the enzyme activity. KN-93, a CaMK inhibitor, blocked CaMKII activation and c-fos promoter stimulation by hypoxia. Ectopic expression of an active mutant of CaMKII (pCaMKII290) stimulated c-fos promoter activity under normoxia. Hypoxia increased phosphorylation of CREB at the serine residue 133 (Ser-133), and KN-93 attenuated this effect. Point mutations at the Ca 2ϩ /cAMP-responsive cis-element (Ca/CRE) attenuated, whereas point mutations in the serum-responsive cis-element (SRE) abolished transcriptional activation of c-fos by hypoxia. These results demonstrate that c-fos activation by hypoxia involves CaMK activation and CREB phosphorylation at Ser-133 and requires Ca/CRE and SRE. These observations demonstrate that Ca 2ϩ -dependent signaling pathways play a crucial role in induction of c-fos gene expression, which may underlie long-term adaptive responses to hypoxia.
immediate early genes; voltage-gated calcium channels; calmodulin-dependent kinases; cAMP-responsive element binding protein AN ADEQUATE SUPPLY of oxygen is essential for the survival of mammalian cells. Chronic hypoxia induces phenotypic remodeling, leading to long-term adaptive responses. The molecular mechanisms underlying the adaptations to chronic hypoxia are poorly understood. Activation of specific genes is considered to be an important mechanism by which hypoxia triggers longterm adaptive responses. In general, the genes that are activated by low oxygen fall into two classes: immediate early genes (IEGs), which are induced within minutes after the onset of hypoxia, and late response genes, which are activated more slowly, over hours (see Ref. 6) . c-fos is one of the most extensively investigated members of the IEG family (14) . Hypoxia stimulates c-fos expression both in vivo (9, 13, 26) and in vitro (25, 28, 29) . The Fos protein forms a heterodimeric complex with Jun, the protein product of another IEG. Fos-Jun heterodimers or Jun-Jun homodimers bind to the DNA sequence TGACTCA, the consensus binding site for the transcription factor activator protein-1 (AP-1) (2). Using reporter gene assays, we have previously shown that hypoxia increases AP-1 activity and antisense c-fos prevents AP-1 activation by low oxygen (17) , suggesting that c-fos is essential for the formation of the AP-1 complex during hypoxia. Many of the late response genes that are activated during hypoxia contain AP-1 consensus binding sites in their promoter regions. Consequently, it has been proposed that c-fos regulates the expression of late response genes during hypoxia (7) . Consistent with this idea, antisense c-fos (17) , as well as mutations in AP-1 binding sites (17, 22) , abolishes the activation of the tyrosine hydroxylase gene during low oxygen. These studies suggest that c-fos participates in cellular adaptations during hypoxia by regulating certain late response genes, such as tyrosine hydroxylase, via formation of the AP-1 transcription factor.
Despite its potential role in cellular adaptations during hypoxia, little is known about the mechanisms underlying c-fos activation by low oxygen. Ca 2ϩ -dependent signaling pathways are critical for c-fos stimulation by a variety of stimuli, including neuro-transmitters and growth factors (see Ref. 12) . Furthermore, it is well established that hypoxia increases intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) in many cell types (5) . Therefore, in the present study, we determined whether c-fos stimulation by hypoxia requires elevation of [Ca 2ϩ ] i , and, if so, we aimed to identify the Ca 2ϩ -dependent signaling pathways associated with the activation of c-fos by low oxygen. Using rat pheochromocytoma-12 (PC-12) cells as a model, we demonstrate that c-fos activation by hypoxia requires Ca 2ϩ influx through L-type voltage-gated Ca 2ϩ channels and is dependent on the activation of Ca 2ϩ /calmodulin-dependent protein kinases (CaMKs) . Our results further demonstrate that both Ca 2ϩ /cAMP-responsive and serum-responsive cis-elements (Ca/CRE and SRE, respectively) are essential for transcriptional activation of c-fos by low oxygen.
METHODS
Cell culture. PC-12 cells (from Dr. K. Neet, Finch University of Health Sciences/Chicago Medical School; original clone from Dr. L. Greene) were grown in a humidified incubator at 37°C circulated with 10% CO 2 and 21% O 2 . The growth medium (DMEM) was supplemented with 10% horse serum and 5% fetal bovine serum (FBS) containing 100 U/ml penicillin and 100 µg /ml streptomycin. Cells were grown to ϳ80% confluency. Before the experiment, cells were placed in lowserum-containing medium (0.5% FBS) for 18 h. Cells were exposed to normoxia (21% O 2 and 10% CO 2 balanced with N 2 ) or to hypoxia (1% O 2 and 10% CO 2 balanced with N 2 ) in an oxygen-regulated incubator (Heraeus) for 3 h unless otherwise indicated. In the experiments involving treatment with drugs, cells were preincubated for 30 min with different concentrations of drugs or vehicle and were then subjected to either hypoxia or normoxia.
Reagents. The following chemicals and reagents were used: lipofectamine, FBS, horse serum, DMEM (Life Technologies, Gaithersburg, MD), primary antibodies against CaMKII and CaMKIV raised against regulatory domain (Transduction Labs, Lexington, KY), and phosphospecific cAMP-responsive element binding protein (CREB) [at serine residue 133 (Ser-133)] and CREB antibodies (New England Biolabs). We obtained affinity-purified horseradish peroxidase-conjugated goat anti-mouse and goat anti-rabbit antibody from Santa Cruz; [␥-32 P]ATP and [␥-32 P]dCTP from NEN-DuPont (Boston, MA); nitrendipine from Research Biochemical International (Natick, MA); KN-93, 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid (BAPTA)-AM, and BAY K 8644, from Calbiochem (La Jolla, CA); the luciferase assay kit from Promega; the ␤-galactosidase assay kit from Tropix; and TRIReagent from Molecular Research Center (Cincinnati, OH). All reagents for RT-PCR assay were from Perkin-Elmer Cetus. Other reagents used in this study were of analytical grade and obtained from Sigma Chemical. Stock solutions of KN-93, BAPTA-AM, and nitrendipine were made in DMSO, whereas BAY K 8644 was made in methanol.
Plasmids. The following plasmids were used in the present study: pfos-LUC, pCaMKII, pCaMKII290, pCGN, and pRSVLacZ. Wild-type and Ca/CRE c-fos promoters with chloramphenicol acetyltransferase reporter were provided by Dr. Gilman (11) and were reconstructed with luciferase reporter gene as described previously (27) . A detailed description of the wild-type and active mutant of CaMKII (CaMKII290) was published previously (27) . The ␤-galactosidase-expressing plasmid pRSV-LacZ was from American Type Culture Collection (16) .
Measurement of c-fos mRNA. c-fos mRNA was analyzed by an RT-PCR assay as described previously (27) . Briefly, total RNA was isolated with TRIReagent and then treated with RNase-free DNase I (Boehringer, Indianapolis, IN) for 1 h at room temperature. For reverse transcription, 0.5 µg of total RNA was added to a reaction mixture of 20 µl containing 5 mM MgCl 2 , 1 mM of each of deoxynucleotide triphosphates, 2.5 µM of random hexamers, 50 mM KCl, 20 mM Tris · HCl (pH 8.3), 1 unit of RNase inhibitor, and 2.5 units of RT. The reaction mixture was incubated at 25°C for 15 min and then incubated at 42°C for 30 min. The reaction was terminated by heating to 95°C for 5 min and flash cooling on ice. The prepared cDNA was stored at Ϫ70°C until further use; 2 µl of the reverse-transcribed material (cDNA) were used for PCR amplification. The reaction mixture (20 µl) contained 50 mM KCl, 10 mM Tris · HCl (pH 8.3), 2 mM MgCl 2 , 1.5 µg each of upstream and downstream primers, 1 µCi [␥-32 P]dCTP (3,000 Ci/mmol), and 0.75 units of Taq polymerase. The reaction mixture was amplified for 30 cycles with the following cycle profile: denaturation for 45 s at 94°C, annealing for 45 s at 56°C, and extension for 1 min at 72°C. In preliminary experiments, we optimized the PCR conditions and product amplifications and found them to be linear up to 30 cycles for both ␤-actin and c-fos. Ten microliters of the PCR products were electrophoresed on 1.5% agarose gels. Gels were stained with ethidium bromide, and radioactive products were visualized after exposure of the dried gels to Kodak film and quantified using PhosphorImager (Molecular Dynamics).
Reporter gene assays. Cells were transfected with one or more of the plasmids, depending on the experimental protocol, as described previously (17) . Briefly, cells were plated in 60-mm tissue culture plates at a density of 5 ϫ 10 5 cells/plate in growth medium containing serum. For transfection, DNAliposome mixture was prepared using 10 µg of lipofectamine, 1 µg of pfos-LUC, and 0.25 µg of pRSV ␤-galactosidase (internal control for determining the transfection efficiency) in 2 ml of serum-free medium. Cells were incubated in the DNA-liposome mixture (2 ml/plate) for 4 h followed by addition of 2 ml of medium. After 36 h, cells were exposed to hypoxia for the desired durations. Total amount of DNA to be transfected per plate was maintained equal by adding pUC19 DNA. Control experiments were run in parallel in normoxia and also by transfecting cells with vector alone.
After exposure to either normoxia or hypoxia, cells were washed with PBS and lysed in 200 µl of reporter lysis buffer (Promega). The cell lysate was spun at 10,000 g for 5 min to remove debris. Ten microliters of the cell lysate were mixed with 100 µl of buffer containing luciferin as a substrate. Relative luminescent light units were recorded in a Berthold luminometer. For measurements of ␤-galactosidase activity, 10 µl of lysate were incubated with 200 µl of the reaction mixture containing ␤-Galactam as substrate for 30 min at room temperature. After incubation, 300 µl of luminescence enhancer were added to the reaction mixture and the resulting luminescence was measured with the luminometer. All reporter gene assays were in the linear range.
Western blot analysis. Proteins were separated on nonreducing 10% SDS-PAGE gels. Resolved proteins were transferred onto Immobilon membranes (Millipore, Bedford, MA) at 40 V/mm 2 for 2 h at 20°C using a Bio-Rad transblot apparatus. After transfer, the membranes were blocked overnight in TBS-T (0.1% Tween 20 and 20 mM Tris-buffered saline, pH 7.6) containing 5% BSA at 4°C. Membranes were incubated with the appropriate primary antibodies for 1 h at 25°C and then washed three times in TBS-T every 5 min. Monoclonal antibodies raised against the regulatory domain of CaMKII or CaMKIV (Transduction Laboratories) were used. Membranes were then incubated for 1 h with the appropriate secondary antibodies conjugated with horseradish peroxidase in TBS-T containing 1% BSA. Membranes were washed three times for 5 min each in TBS-T. Protein bands were detected by an enhanced chemiluminescence detection system (Amersham). The membranes were exposed to Kodak XAR films.
Measurements of CaMKII activity by in vitro kinase assay. Cells were plated at a density of 4 ϫ 10 6 /100-mm dish. Eighteen hours before experiments, cells were placed in medium containing low serum (0.5% FBS). After the hypoxic exposure, cells were lysed in buffer containing 25 mM HEPES (pH 7.4), 150 mM NaCl, 2.5 mM MgCl 2 , 0.1 mM EDTA, 0.5 mM dithiothreitol, 20 mM glycerophosphate, 1 mM sodium orthovanadate, 2 µg/ml leupeptin, 100 µg/ml phenylmethylsulfonyl fluoride, and 1% NP-40 on ice for 20 min. Cell debris was removed by centrifugation at 10,000 g for 10 min. Protein was assayed by a protein assay kit (Bio-Rad), using BSA as a standard. The standard curve for the kinase assay was constructed according to the protocols suggested by the manufacturer (CaMKII assay kit; Upstate Biotechnology). The reaction mixture was 30 µl of solution containing 50 mM HEPES (pH 7.5), 10 mM MgCl 2 , 0.1 mM [␥-32 P]ATP, 125 µM autocamtide, and 400 ng of calmodulin. Activities of other serine/threonine kinases such as protein kinase A and protein kinase C were inhibited by 0.2 µM of inhibitor peptide. The reaction was initiated by adding 10 µl of cell supernatant (equal amount of protein). After incubation at 30°C for 15 min, 10-µl aliquots were spotted on p81 phosphocellulose paper. After 3 min, the paper was immersed in 0.75% phosphoric acid and washed 10-15 times and then washed in acetone for 5 min with five changes. The radioactivity was counted by a scintillation counter.
Measurements of Ca 2ϩ currents. Ca 2ϩ current was monitored using the whole cell configuration of the patch-clamp technique as described previously (23) . Briefly, currents were recorded using an Axopatch 200A voltage-clamp amplifier, filtered at 5 kHz, and sampled at a frequency of 10 kHz using an IBM-compatible computer with a Digidata 1200 interface and pCLAMP software (Axon Instruments). Currents were not leak subtracted. Current-voltage relations were elicited from a holding potential of Ϫ80 mV using 50-ms steps (5 s between steps) to test potentials over a range from Ϫ50 to ϩ50 mV in 10-mV increments. Current at each potential was measured as the average over a 2.5-ms span at the end of the step. Ca 2ϩ current was isolated using K ϩ -and Na ϩ -free intracellular and extracellular solutions. The intracellular solution had the following composition (in mM): 130 CsCl, 20 tetraethylammonium chloride, 5 MgATP, 0.1 Tris-GTP, 5 EGTA, and 5 HEPES; pH was adjusted to 7.2 with CsOH. The extracellular solution contained (in mM) 140 N-methylglucamine chloride, 5.4 CsCl, 10 BaCl 2 , 10 HEPES, and 11 glucose; pH was adjusted to 7.4 with CsOH. Extracellular solutions were made hypoxic by degassing under vacuum for 1 h and then continuously bubbling with hypoxic gas mixture before and during experiments. The extracellular solution was changed using a fast-flow apparatus consisting of a linear array of borosilicate glass tubes (23) . In these experiments, Ba 2ϩ was the charge carrier. For simplicity, Ba 2ϩ current conducted by Ca 2ϩ channels will be referred to as Ca 2ϩ current.
Data analysis. The data are expressed as means Ϯ SE from three to five individual experiments, each run in duplicate. Statistical analysis was performed by ANOVA or by paired t-test where appropriate. P values Ͻ0.05 were considered significant.
RESULTS

Effects of BAPTA on c-fos mRNA induction and transcriptional activation by hypoxia.
To determine whether activation of c-fos mRNA requires increases in [Ca 2ϩ ] i , cells were exposed for 30 min to varying concentrations of BAPTA, a Ca 2ϩ chelator; cells were then challenged with hypoxia (1% O 2 ) for 3 h. Experiments without BAPTA in the medium served as controls. As shown in the example in Fig. 1A , top, c-fos mRNA increased during hypoxia and BAPTA abolished the effects of low oxygen in a concentration-dependent manner. Average results are summarized in Fig. 1A , bottom. BAPTA at submicromolar concentrations (e.g., 0.1 µM) reduced and BAPTA at micromolar concentrations (3 µM) abolished c-fos activation by hypoxia. However, under normoxia, BAPTA (3 µM) by itself had no effect on c-fos expression. Furthermore, neither hypoxia nor BAPTA-AM had any significant effect on ␤-actin mRNA, which served as controls.
Hypoxia also increases c-fos transcription in PC-12 cells (25) . Therefore, we investigated whether Ca 2ϩ is required for transcriptional activation of c-fos by hypoxia. The c-fos promoter activity was monitored by a reporter gene assay using a luciferase expression vector. As shown in Fig. 1B , hypoxia increased c-fos promoter activity, and this effect was abolished by 3 µM BAPTA (P Ͻ 0.01; n ϭ 5). In cells transfected with expression vector (pGL3) lacking the c-fos promoter, hypoxia had no effect on luciferase activity (P Ͼ 0.05; n ϭ 5). Neither hypoxia nor BAPTA had any significant effect on ␤-galactosidase activity, which served as a control for assessing the transfection efficiency (␤-galactosidase/mg of protein; normoxia vs. hypoxia, P Ͼ 0.05; n ϭ 5).
Effects (24) . Therefore, we investigated whether hypoxia-induced c-fos activation is linked to the activation of L-type Ca 2ϩ channels. As shown in Fig. 2A , nitrendipine, a specific L-type Ca 2ϩ channel blocker, abolished c-fos mRNA induction by hypoxia in a concentration-dependent manner. Average data showed that 1 µM nitrindipine reduced c-fos mRNA activation by 60%, whereas 3 µM completely prevented the response to hypoxia. At higher concentrations (10 µM), nitrendipine tended to affect basal c-fos expression under normoxia, whereas 3 µM nitrendipine had no significant effect on basal c-fos expression. Therefore, in all further experiments, we chose to study 3 µM nitrendipine. To further establish the involvement of L-type Ca 2ϩ channels, the effect of (Ϫ)BAY K 8644, an L-type Ca 2ϩ channel agonist, was tested on c-fos mRNA activation by hypoxia. As illustrated in Fig. 2B , BAY K 8644 (1 µM) significantly enhanced c-fos activation by hypoxia (controls vs. BAY K 8644, P Ͻ 0.01). Figure 2C summarizes the effects of nitrendipine and BAY K 8644 on c-fos promoter activation by hypoxia. As can be seen, 3 µM nitrindipine prevented and 1 µM BAY K 8644 enhanced c-fos promoter activation by hypoxia (P Ͻ 0.01; n ϭ 5). The effects of hypoxia on Ca 2ϩ currents were examined using the whole cell configuration of the patchclamp technique (n ϭ 9) in another series of experiments. The currents recorded were noninactivating and of high threshold (activated at membrane voltages of greater than Ϫ30 mV). The Ca 2ϩ current was decreased by 70 Ϯ 14% (0 mV; n ϭ 3) by nitrendipine (2 µM), indicating that the current is conducted predominantly by L-type Ca 2ϩ channels. Hypoxia (comparable levels used in the above experiments) reversibly augmented the Ca 2ϩ current in seven of nine cells tested. An example of the effect of hypoxia on Ca 2ϩ current is shown in Fig. 3A . The effect of hypoxia on Ca 2ϩ current was further examined over a range of membrane potentials from Ϫ50 to ϩ50 mV. Augmentation was stronger at more negative membrane potentials, suggesting that it was voltage dependent. This is shown in Fig. 3B , which shows the percent augmentation of the control current by hypoxia as a function of membrane potential. The augmentation was significant over the range of Ϫ20 to 0 mV (P Ͻ 0.05, paired t-test; n ϭ 7). Fig. 4A , a protein band corresponding to CaMKII could readily be detected in PC-12 cells, whereas protein corresponding to CaMKIV was not evident. However, protein bands corresponding to both CaMKII and CaMKIV could readily be seen in Hep 3B cells, which served as controls. To determine whether hypoxia increases CamKII activity, cells were exposed to hypoxia and CaMKII activity was determined by in vitro kinase assay. Hypoxia resulted in a significant activation of CaMKII (Fig. 4B) . This activation was transient in that it returned to basal levels after 1 h of hypoxia (Fig. 4B) . Furthermore, KN-93 (10 µM), a selective pharmacological inhibitor of CaMKs, prevented hypoxia-induced CaMKII activation (P Ͻ 0.01; Fig. 4C ).
Effects of CaMK inhibitor and ectopic expression of the active mutant of CaMKII on c-fos promoter activation by hypoxia. One of several mechanisms by which Ca 2ϩ regulates c-fos gene expression is through the activation of CaMKs, especially CaMKII and CaMKIV (see Ref. 12). As shown in
To determine whether CaMKs contribute to the activation of c-fos promoter by hypoxia, cells were transfected with fos-luciferase construct and then exposed to low oxygen in the presence of 10 µM KN-93; c-fos promoter activation by hypoxia was abolished by KN-93 (Fig. 5A) . On the other hand, KN-93 (10 µM) had no effect on basal fos-luciferase activity (P Ͼ 0.05). To further determine the specific involvement of CaMKII, cells were transfected with a constitutively active mutant of CaMKII (pCaMKII290) along with the fosluciferase construct. Cells transfected with a wild-type CaMKII or with vector alone (pCMV) served as controls. We reasoned that if c-fos stimulation by hypoxia requires activation of CaMKII, then cells expressing constitutively active CaMKII, but not the wild-type CaMKII, increase basal levels of c-fos and should occlude the effects of hypoxia. Results summarized in Fig. 5B confirm this idea. It can be seen that c-fos promoter activity was sixfold greater in cells transfected with the active mutant of CaMKII than in those overexpressing wild-type CaMKII (pCMVCaMKII) or vector alone (pCMV). Furthermore, hypoxia had no further stimulatory effect on c-fos promoter activity in cells overexpressing the active mutant of CaMKII (P Ͼ 0.05; n ϭ 5).
Effect of hypoxia on phosphorylation of CREB at Ser-133. The following series of experiments were performed to identify signaling pathways in c-fos expression by hypoxia downstream to CaMKs. CREB is a transcription factor that is involved with transcriptional regulation of several genes, including c-fos (12) . CaMKs are one of the CREB kinases that stimulate phosphorylation at Ser-133, and phosphorylation of CREB at Ser-133 is essential for stimulation of c-fos transcription by other stimuli (12) . To determine whether hypoxia increases CREB phosphorylation at Ser-133 and whether CaMKs are involved in this response, cells were exposed to hypoxia and phosphorylation of CREB at Ser-133 was analyzed by immunoblot assay using antibodies specific for the phosphorylated form of CREB at residue Ser-133. As shown in Fig. 6 , hypoxia increased CREB phosphorylation at Ser-133 but had no effect on CREB protein levels (Fig. 6) . Furthermore, the CaMK inhibitor, KN-93 (10 µM), significantly attenuated hypoxia-induced CREB phosphorylation at Ser-133 (P Ͻ 0.01; n ϭ 4).
Effect of point mutations in Ca/CRE and SRE on c-fos promoter activation by hypoxia. CREB constitutively binds to Ca/CRE in the c-fos promoter. Phosphorylation of CREB at Ser-133 promotes c-fos transcription by transactivation of Ca/CRE (12) . To assess whether CREB phosphorylation induced by hypoxia is linked to c-fos activation, we transfected cells with c-fos-luciferase plasmid with point mutations in Ca/ CRE (C-to-G conversions, point mutation 3), which prevents constitutive binding of CREB to Ca/CRE. Transfected cells were exposed to either hypoxia or 20% FBS, another potent stimulator of c-fos promoter activity (27) ; the latter served as controls. The results are summarized in Fig. 7 . Hypoxia increased c-fos promoter activity in cells transfected with wild-type construct. However, point mutation in Ca/CRE significantly attenuated but did not completely block c-fos promoter activation by hypoxia (Fig. 7) . As expected, FBS-induced stimulation of the c-fos promoter activity, which can activate c-fos independent of Ca/CRE, was unaffected by point mutation in Ca/CRE. SRE is required for c-fos activation by hypoxia in HeLa cells (21) . Therefore, we determined whether SRE is also needed for c-fos activation by low oxygen in PC-12 cells. Cells were transfected with a c-fosluciferase construct containing an inactivating point mutation in the CArG sequence [i.e., serum response factor (SRF) binding site] of the SRE (pm 12; Fig. 7 ). Mutations at SRE completely abolished c-fos promoter activation by hypoxia. As expected, mutations in SRE also prevented c-fos promoter activation by FBS (Fig.  7) . These results show that both Ca/CRE and SRE are required for c-fos activation by hypoxia.
DISCUSSION
The objective of the present study was to identify the signaling pathways that link the hypoxic stimulus to c-fos gene expression. Our results demonstrate that Ca 2ϩ influx through L-type voltage-activated Ca 2ϩ channels is essential for c-fos activation by hypoxia and depends on CaMK and CREB phosphorylation at Ser-133. In addition, transcriptional activation of c-fos by hypoxia requires Ca/CRE and SRE.
c-fos activation by hypoxia requires Ca 2ϩ influx through L-type voltage-gated Ca 2ϩ channels. Several observations in the present study suggest that activation of Ca 2ϩ influx through L-type voltage-gated Ca 2ϩ channels is an initial step in the signaling cascade that regulates the c-fos expression during hypoxia. First, nitrendipine, an antagonist of L-type voltage-gated Ca 2ϩ channels, blocked and BAY K 8644, an agonist of these channels, enhanced c-fos induction by hypoxia. Second, the Ca 2ϩ chelator BAPTA, which is expected to prevent the rise in [Ca 2ϩ ] i , inhibited c-fos mRNA induction by hypoxia. However, whether hypoxia activates voltage-gated Ca 2ϩ channels is controversial. In pulmonary arterial smooth muscle cells (cells from resistant vessels), hypoxia augments Ca 2ϩ currents (10) . However, in carotid body glomus cells, hypoxia inhibits Ca 2ϩ currents (19) . In the present experiments on PC-12 cells, hypoxia augmented Ca 2ϩ currents in a voltagedependent manner. These observations are similar to those reported in pulmonary artery smooth muscle cells (10) . The currents were sensitive to nitrendipine, suggesting that hypoxia-sensitive Ca 2ϩ currents are conducted by L-type voltage-gated Ca 2ϩ channels in PC-12 cells. However, from these experiments, we cannot rule out the involvement of other types of high-voltage-activated Ca 2ϩ channels. None the less, these observations with patch-clamp experiments further support the idea that c-fos activation by hypoxia in PC-12 cells requires Ca 2ϩ influx through activation of L-type Ca 2ϩ channels. Hypoxia also stimulates c-fos mRNA in nonexcitable cells such as Hep 3B (25) (Fig. 4) . Hypoxiainduced CaMKII activation is rapid and occurs within minutes after the onset of the stimulus. However, it is transient in that enzyme activity returned to basal levels with longer exposure to hypoxia. This pattern of CaMKII activation by hypoxia is similar to that reported with other stimuli (18) . A recent study reported that CaMKII activity was unaltered or downregulated in PC-12 cells (4). However, these investigators examined the CaMKII activity in cells exposed to 1 h or longer durations of hypoxia. Although the long-term effects of hypoxia (i.e., more than 3 h) were not investigated in this study, we did observe that CaMK activity returns to baseline after 1 h of hypoxia. Most importantly, a number of findings in the present study argue for a role of CaMKII in transcriptional regulation of c-fos by hypoxia. First, CaMKII activation preceded c-fos transcriptional activation, which required hours. Second, a pharmacological antagonist of CaMK, KN-93, not only prevented CaMKII activation but also, more importantly, blocked c-fos promoter activation by hypoxia and had no effect on basal fos-luciferase activity. Third, ectopic expression of an active mutant (pCaMKII290), but not the wild-type CaMKII, mimicked the effects of hypoxia on c-fos transcriptional activation. Together, these observations support a role for CaMKII in the activation of the c-fos promoter by low oxygen. Future experiments with a dominant negative mutant of CaMKII may further support the role of CaMKII. It should, however, be pointed out that Ca 2ϩ influx also activates CaMKI in PC-12 cells (1). It remains to be established whether CaMKI also contributes to transcriptional activation of c-fos by hypoxia.
To further identify the signaling events that link CaMKs to c-fos transcription, we examined the effects of hypoxia on CREB phosphorylation at Ser-133 because CaMKII is one of the kinases that stimulates CREB phosphorylation at Ser-133 (12) . Our results demonstrate that hypoxia increases CREB phosphorylation at Ser-133. These observations are consistent with one recent report (3) . However, these authors reported that EGTA and/or omission of Ca 2ϩ in the medium did not prevent hypoxia-induced CREB phosphorylation at Ser-133. On the basis of these results, these authors (3) concluded that CaMKs do not contribute to hypoxia-induced CREB phosphorylation. However, in the present study, we found that the CaMK inhibitor, KN-93, consistently inhibited CREB phosphorylation by hypoxia. Although we did not test the effects of EGTA, based on the data with KN-93, we believe that CaMKs contribute to CREB phosphorylation during hypoxia. Because KN-93 did not completely abolish the response, it is possible that, in addition to CaMKs, other pathways might be contributing to CREB phosphorylation by hypoxia, as suggested by other investigators (3).
Members of the CREB family of transcription factors (12) constitutively occupy the Ca/CRE. Phosphorylation of CREB at the transcriptional regulatory residue Ser-133 is critical for the transactivation of Ca/CRE (12) . Our results demonstrated that a point mutation in Ca/CRE (C-to-G conversion), which prevents binding of CREB, attenuated c-fos promoter activation by hypoxia. This attenuation is not a nonspecific effect because c-fos promoter activation by serum is unaffected by the point mutation at Ca/CRE. Together, these observations suggest that hypoxia-induced CREB phosphorylation at Ser-133 is linked to transcriptional activation of c-fos through transactivation of Ca/CRE. Interestingly, point mutation at Ca/CRE attenuated but did not abolish c-fos promoter activation, suggesting that other cis-elements also participate in transcriptional activation of c-fos by hypoxia. It is known that SRE also participates in c-fos stimulation by Ca 2ϩ (18) . We also found that point mutation in the CArG sequence (i.e., SRF binding site) of the SRE abolished c-fos promoter activation by hypoxia. These observations are similar to those in a recent report on HeLa cells, in which mutations at the Ets binding motif of SRE prevented c-fos promoter activation by hypoxia (21) . The fact that point mutations in SRE abolish and in Ca/CRE cause only a partial blockade suggests that cooperativity between the two cis-elements is necessary for transcriptional activation of c-fos by hypoxia.
Hypoxia is a pervasive natural stimulus that occurs in many physiological (e.g., high altitude) and pathophysiological (e.g., chronic lung diseases) situations. It is well documented that Ca 2ϩ signaling pathways play an important role in the physiological responses to acute hypoxia, one such example being the release of neurotransmitters from PC-12 cells (15) and from carotid body glomus cells (19) by low oxygen. The present results demonstrate that Ca 2ϩ -dependent signaling pathways also play a crucial role in the induction of c-fos gene expression in excitable cells, which, by way of AP-1 transcription factor, contribute to longterm adaptive responses to hypoxia.
